Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.
Rat Cortical Oligodendrocyte-Embryonic Motoneuron Co-Culture: An In Vitro Axon-Oligodendrocyte Interaction Model.
Patient Characteristics Associated with Medication Adherence.
Factors for lower walking speed in persons with multiple sclerosis.
Requirement for interleukin-1 to drive brain inflammation reveals tissue-specific mechanisms of innate immunity.
Electrodiagnostic criteria for Guillain-Barrè syndrome: A critical revision and the need for an update.
Body mass index and waist circumference in persons aging with muscular dystrophy, multiple sclerosis, post-polio syndrome, and spinal cord injury.
The role of the parent compound vitamin d with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes.
Fully automatic detection of deep white matter T1 hypointense lesions in multiple sclerosis.
A selective thyroid hormone β receptor agonist enhances human and rodent oligodendrocyte differentiation.
Affinity Proteomic Profiling of Plasma, Cerebrospinal Fluid, and Brain Tissue within Multiple Sclerosis.
Diurnal fluctuations in brain volume: Statistical analyses of MRI from large populations.
Perception of affective prosody in patients at an early stage of relapsing-remitting multiple sclerosis.
Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis.
Multiple sclerosis: from molecules to treatment.
Platelets and autoimmunity.
Drainage of Cells and Soluble Antigen from the CNS to Regional Lymph Nodes.
How microglia kill neurons.
Paradoxical inflammation induced by anti-TNF agents in patients with IBD.
Genetic inactivation of mitochondria-targeted redox enzyme p66ShcA preserves neuronal viability and mitochondrial integrity in response to oxidative challenges.
Immunopathological patterns from EAE and Theiler's virus infection: Is multiple sclerosis a homogenous 1-stage or heterogenous 2-stage disease?
Glycopeptide-based antibody detection in multiple sclerosis by surface plasmon resonance.
Injury to a specific neural pathway detected by Ultra-high-field MRI.
Treatment of multiple sclerosis in children and its challenges.
Lynoral: How To Order
Pages
« first
‹ previous
…
338
339
340
341
342
343
344
345
346
…
next ›
last »